EFFECTS OF TELENURSING IN PREDIALYSIS PATIENTS (NCT07669142) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
EFFECTS OF TELENURSING IN PREDIALYSIS PATIENTS
Turkey (Türkiye)66 participantsStarted 2026-05-15
Plain-language summary
This study aims to evaluate the effect of tele-nursing practices on quality of life and clinical outcomes in predialysis patients with chronic kidney disease. The study will be conducted with patients diagnosed with stage 3A, 3B, or 4 chronic kidney disease who are followed in a nephrology outpatient clinic.
Participants will be assigned to intervention and control groups. Patients in the intervention group will receive a structured tele-nursing program including patient education, telephone or online follow-up, reminders, and counseling for disease management. Patients in the control group will continue to receive routine outpatient care.
Quality of life, medication adherence, self-care management, blood pressure, body weight, edema status, and laboratory parameters such as eGFR, creatinine, blood urea nitrogen, potassium, phosphorus, calcium, albumin, hemoglobin, and bicarbonate will be evaluated at baseline, 3 months, and 6 months. The study is expected to show whether tele-nursing support can improve quality of life, self-care behaviors, treatment adherence, and clinical outcomes in predialysis patients.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being 18 years of age or older Having a diagnosis of stage 3A, 3B, or 4 chronic kidney disease Having an estimated glomerular filtration rate between 15 and 59 mL/min/1.73 m² Being followed in the nephrology outpatient clinic for at least 3 months Not receiving dialysis treatment Being able to communicate in Turkish Having access to a telephone or smart device suitable for tele-nursing follow-up Being able to participate in telephone, messaging, or online follow-up Voluntarily agreeing to participate in the study Providing informed consent
Exclusion Criteria:
* Having stage 1,2 and 5 chronic kidney disease Receiving hemodialysis or peritoneal dialysis treatment Having a history of acute kidney injury within the last 3 months Having a terminal illness Having severe cognitive impairment, psychiatric disorder, or communication problem that prevents participation in the study Having hearing, speech, or visual impairment that prevents effective tele-nursing communication Not having access to the required communication tools for remote follow-up Participating in another interventional study that may affect the outcomes of this research Refusing to participate in the study Withdrawing informed consent during the study period
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Kidney Disease Quality of Life-36 (KDQOL-36) score change from baseline to 6 months